In a striking revelation, Dr. Nicholas DeVito, a prominent oncologist from Duke University in North Carolina, has sounded the alarm over a disturbing trend in cancer diagnoses. According to Dr. DeVito, every new cancer patient entering his clinic is now under 45 years old. This demographic shift has raised significant concerns, as the number of young cancer patients has surged to unprecedented levels.

Dr. DeVito’s observations reflect a dramatic change in the cancer landscape. “At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and other gastrointestinal cancers, I remarked to a colleague, ‘Every new patient on my schedule is under 45.’ She replied, ‘Three of mine are… this is too many young people with cancer.’ We felt as though we were in the trenches and didn’t know where the bullets were coming from,” he recounts.

This alarming trend has not gone unnoticed. Dr. DeVito and his colleagues are increasingly concerned about the rising incidence of aggressive cancers, which they refer to as “turbo cancers.” The timing of this surge coincides with the widespread rollout of COVID-19 vaccines, sparking a heated debate about a potential link between the vaccines and the rising cancer rates among younger populations.

The data showing a spike in cancer cases starting in 2021, shortly after the COVID-19 vaccines became widely available, has fueled speculation. Critics argue that the surge in cancer diagnoses could be linked to the vaccines, which were introduced as a response to the COVID-19 pandemic. These vaccines were rolled out at unprecedented speed, raising questions about their long-term effects on health.

NEWS: Top Oncologist Raises Alarm: "Every New Cancer Patient Is Under 45" – COVID-19 Vaccine Induced Turbo Cancer Tsunami is coming for the young

A leading oncologist is raising the alarm about the staggering surge in cancer cases among young people.

North Carolina‘s Duke… pic.twitter.com/Kmv9YOvTDV

— William Makis MD (@MakisMD) September 14, 2024

Dr. Nicholas DeVito’s recent observations have ignited a crucial discussion about the rising incidence of cancer among young people and its potential links to the COVID-19 vaccines. As this issue continues to unfold, it is essential for all stakeholders—health officials, researchers, and the public—to engage in open and honest discussions.